Comment by
Boomskid on Jan 12, 2023 11:13am
Midatech is struggling to stay above 70¢ today, despite the glioblastoma news. (Last rade was at 68¢) At 70¢, Bioasis shareholders would be getting about 3.6¢ CDN per share. JD
Comment by
craighenry on Jan 12, 2023 11:26am
Nope! Only YOU can "read between the lines" hey JBroke? LMFAO
Comment by
Boomskid on Jan 12, 2023 11:29am
At 3.6¢ per share, Craig, I would think the entire market is reading between the lines. Go ahead. Make my case. Argue against the market. lmfao jd
Comment by
Boomskid on Jan 12, 2023 11:44am
You keep quacking, Craig. What? You a duck? jd
Comment by
craighenry on Jan 12, 2023 11:48am
Yup. A duck that is not able to "read between the lines"!!! And a duck that wont be investigated for leaking material information when under a NDA!
Comment by
Boomskid on Jan 12, 2023 12:40pm
Find the quotes where I gave such investment advice, Craig. jd
Comment by
craighenry on Jan 12, 2023 12:43pm
Dont worry Bud. We got em'!! Your done JBoke!
Comment by
OttawaPeter on Jan 14, 2023 8:43pm
That's just WRONG, man! Bioasis MUST pay you, per the terms of your contract. Bioasis needs to list what they owe you as part of their debts in their quarterly & annual reporting. If not included, their reporting isn't accurate and must be reporterd. Had no idea Bioasis/DR did that and, as a SH, I find it appalling.
Comment by
Boomskid on Jan 12, 2023 11:31am
So, poof, now you're going to argue against the deal. Well, I guess you're buying cheap MTP stock today and a new opinion suits your new trade. Go ahead. Make my case. Argue against the market. jd
Comment by
Boomskid on Jan 12, 2023 11:48am
MTP down to USD $0.6732, making BTI worth CDN 3.45¢ That's between the lines of little and nothing. jd